Not Tagged
Not Tagged
['mibc', 'retain trial', 'gi ', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
retain trial risk stratified approach to mibc with nac and observation median f/u 41mo although did not meet primary endpoint if mfs, however 46% as patients alive w/o recurrence and 2 year as and non as mfs equivalent. 10 patients with met dz, 8 recurred locally 1st #gu23 
@UroOnc fellow @FCUroOnc @caseurology @JohnsHopkinsSPH grad/👦👦👦🐶mom/Health outcomes/translational 🔬 bladder@AbboshLab 🧪 Immunology @DrexelUniv